Improving COPD outcomes through enhanced inhaler education and technique
Can't see this email? View it online
   
  Pulmonology Pulmonology logo  
  The latest pulmonology news from News Medical  
 Chronic cough can be passed down from parents to children, a new study suggestsChronic cough can be passed down from parents to children, a new study suggests
 
Research indicates chronic cough is potentially inherited, with parents' cough types influencing their children's respiratory health and conditions.
 
 
 Improving COPD outcomes through enhanced inhaler education and techniqueImproving COPD outcomes through enhanced inhaler education and technique
 
Inhaler misuse leading to inadequate medication delivery impacts a person's ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper inhaler use is needed to improve health outcomes, according to two new articles. The articles are published in the July 2024 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open-access journal.
 
   Experts release revised lung cancer testing guidelinesExperts release revised lung cancer testing guidelines
 
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced today the open comment period for the revised 2018 evidence-based guideline, "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors."
 
   AmoyDx® Pan Lung Cancer PCR Panel approved in Japan as a companion diagnostic for Haiyitan® tablets (gumarontinib)AmoyDx® Pan Lung Cancer PCR Panel approved in Japan as a companion diagnostic for Haiyitan® tablets (gumarontinib)
 
Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the AmoyDx® Pan Lung Cancer PCR Panel
 
   New AI-driven platform enhances lung cancer tissue analysisNew AI-driven platform enhances lung cancer tissue analysis
 
A team of researchers from the University of Cologne's Faculty of Medicine and University Hospital Cologne, led by Dr Yuri Tolkach and Professor Dr Reinhard Büttner, has created a digital pathology platform based on artificial intelligence.
 
 AI can effectively exclude pathology in chest X-rays
 
AI can effectively exclude pathology in chest X-raysA commercial artificial intelligence (AI) tool used off-label was effective at excluding pathology and had equal or lower rates of critical misses on chest X-ray than radiologists, according to a study published today in Radiology, a journal of the Radiological Society of North America (RSNA).
 
 
 New $5.8 million grant aims to transform the global landscape of TB research
 
New $5.8 million grant aims to transform the global landscape of TB researchA $5.8 million grant led by Adrie Steyn, Ph.D., of the University of Alabama at Birmingham and the Africa Health Research Institute, or AHRI, in Durban, South Africa, will provide user-requested infected human lung tissue and analytical services to tuberculosis researchers worldwide.
 
 
 Bedfont® are thrilled to announce a new partnership with Geratherm® Group
 
Bedfont® are thrilled to announce a new partnership with Geratherm® GroupA door opens to ensure the gold standard of FeNO testing is available in Latin America. Image Credit: Bedfont Scientific Ltd. Bedfont® Scientific Limited, world leaders in breath analysis, with over 47 years of experience in the manufacturing and distribution of breath analysis devices have partnered with worldwide respected medical company Geratherm® Group, to enable them to manufacture a Fractional exhaled Nitric Oxide (FeNO) testing device.
 
 
 Widespread inhaler misuse in COPD patients: Need for training
 
Widespread inhaler misuse in COPD patients: Need for trainingStudy found that 69% of hospitalized COPD patients misused inhalers, with 66% making critical errors, and 14% having insufficient Peak Inspiratory Flow (PIF), even after training.
 
 
 GLP-1 therapy boosts visceral fat metabolism, driving weight loss
 
GLP-1 therapy boosts visceral fat metabolism, driving weight lossResearchers discuss the role of enhanced visceral adipose tissue metabolism in mediating weight loss by glucagon-like peptide-1 drugs.
 
 
 A teen’s murder, mold in the walls: Unfulfilled promises haunt public housing
 
A teen’s murder, mold in the walls: Unfulfilled promises haunt public housingBlocks from where tourists stroll along the cobblestoned riverfront in this racially divided city, Detraya Gilliard made her way down the dark, ruptured sidewalks of Yamacraw Village, looking for her missing 15-year-old daughter.
 
 
 AI tools accelerate understanding of cardiac arrhythmia risks in lung cancer treatment
 
AI tools accelerate understanding of cardiac arrhythmia risks in lung cancer treatmentResearchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, have used artificial intelligence tools to accelerate the understanding of the risk of specific cardiac arrhythmias when various parts of the heart are exposed to different thresholds of radiation as part of a treatment plan for lung cancer.